D-0200-2026 Class II Ongoing

Recalled by Park Avenue Compounding — Saint Louis, MO

FDA drug recall D-0200-2026 was initiated by Park Avenue Compounding on Sep 17, 2025 and is designated Class II. Reason for recall: CGMP Deviations The recall status is ongoing. Affected quantity: 858 syringes.

Recall details

Product Type
Drugs
Report Date
Dec 10, 2025
Initiation Date
Sep 17, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
858 syringes

Product description

Phenylephrine HCI, 1000 mcg / 10 mL, 10 mL Total Volume, Rx Only, Park Avenue Compounding, 3662 Park Ave, Saint Louis, MO, 63110-2512, NDC 83863-0104-1.

Reason for recall

CGMP Deviations

Distribution pattern

MO

Code information

Lot # 20250813-13D65E, Exp Date: FEB-09-2026.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0200-2026
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0200-2026. Report a data issue: hello@regdatalab.com.